On November 17, 2022 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, reported that Gritstone management will participate in the following upcoming investor conferences (Press release, Gritstone Oncology, NOV 17, 2022, View Source [SID1234624201]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

5th Annual Evercore ISI HealthCONx Conference
Fireside Chat Date and Time: Tuesday, November 29, 2022 at 10:30am EST
Presenter: Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer
Location: Virtual
Webcast: View Source

34th Annual Piper Sandler Healthcare Conference
Fireside Chat Date and Time: Thursday, December 1, 2022 at 2:30pm EST
Presenter: Celia Economides, Chief Financial Officer and Matthew J. Hawryluk, Chief Business Officer
Location: New York, NY
Webcast: View Source;tp_key=0164d9de42

The presentations can be viewed live via the Investors & Media section of Gritstone’s website at View Source An archived replay will be accessible for 30 days following the event.